Seethal A Jacob
Overview
Explore the profile of Seethal A Jacob including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
104
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Karkoska K, Jacob S, McGann P
Blood Adv
. 2025 Mar;
PMID: 40085957
Crizanlizumab and voxelotor were several of the first drugs to receive FDA approval for sickle cell disease (SCD) since the approval of hydroxyurea in 1998. Although initially exciting, additional data...
2.
Frey N, LaMotte J, Bouck J, Fancher L, Parker G, Carter A, et al.
BMC Health Serv Res
. 2025 Jan;
25(1):99.
PMID: 39825334
Background: Individuals with Sickle Cell Disease (SCD) are a minoritized and marginalized community that have disparate health outcomes as a result of systemic racism and disease-related stigma. The purpose of...
3.
Brown A, Goubeaux D, Jacob S, Belsky J
Pediatr Blood Cancer
. 2024 Nov;
72(1):e31433.
PMID: 39506326
Children and adolescents and young adults (CAYAs) with sickle cell disease (SCD) suffer from recurrent acute pain episodes that result in hospitalization and confer substantial morbidity. Pharmacologic pain control is...
4.
Catanzarite A, Bouck J, Matthes M, Goubeaux D, Carter A, LaMotte J, et al.
Pediatr Blood Cancer
. 2024 Nov;
72(1):e31422.
PMID: 39502023
Background: Individuals with sickle cell disease (SCD) experience significant healthcare disparities; however, there is little known on the impact of psychosocial stressors and neighborhood disadvantage on preventive and acute care...
5.
Li W, Pucka A, Debats C, Reyes B, Syed F, OBrien A, et al.
Front Immunol
. 2024 Feb;
15:1288187.
PMID: 38361924
Clinical Trial Registration: ClinicalTrials.gov, Identifier: NCT05045820.
6.
Robb S, Stegenga K, Perkins S, Stump T, Moody K, Henley A, et al.
Integr Cancer Ther
. 2023 Dec;
22:15347354231218266.
PMID: 38145309
Objective: This trial examined the effects of proximal/distal mediators and moderators of an Active Music Engagement (AME) intervention on young child/parent distress, quality of life, and family function outcomes. Methods:...
7.
Jacob S, Talati R, Kanter J
Lancet Child Adolesc Health
. 2023 Oct;
7(11):797-808.
PMID: 37858508
Sickle cell disease is the most common inherited pathological haemoglobinopathy. Over the past 30 years, disease-related morbidity and mortality have improved in high-income countries due to advances in preventive care...
8.
Molloy M, Auger K, Hall M, Shah S, Schondelmeyer A, Parikh K, et al.
Pediatrics
. 2023 Oct;
152(5).
PMID: 37791428
Background And Objectives: Multisystem inflammatory syndrome in children (MIS-C) is a novel, severe condition following severe acute respiratory syndrome coronavirus 2 infection. Large epidemiologic studies comparing MIS-C to Kawasaki disease...
9.
Martin O, Hamby D, Graham B, Jacob S
Pediatr Rev
. 2023 Sep;
44(S1):S29-S34.
PMID: 37777240
No abstract available.
10.
Li W, Pucka A, Debats C, Reyes B, Syed F, OBrien A, et al.
medRxiv
. 2023 Sep;
PMID: 37732268
This study aimed to comprehensively analyze inflammatory and autoimmune characteristics of patients with sickle cell disease (SCD) at a steady-state condition (StSt) compared to healthy controls (HCs) to explore the...